?
Home
About
Company Overview
History
Group Structure
ESG
Management Team
R&D
Technology Platform
505(b)(2) NDA
High Barrier ANDA
Corporate
Board of Directors
Committee
Internal Audit
Major Internal Policies
Investor
Company Profile
Financials
Shareholders’ Services
Stakeholder
News
Contact
Location
Join Us
Home
About
Company Overview
History
Group Structure
ESG
Management Team
R&D
Technology Platform
505(b)(2) NDA
High Barrier ANDA
Corporate
Board of Directors
Committee
Internal Audit
Major Internal Policies
Investor
Company Profile
Financials
Shareholders’ Services
Stakeholder
News
Contact
Location
Join Us
R&D
HND-004
Indication
diabetes drug
Status
ANDA filling
Product Advantages
ANDA product
Potential Market
Market research shows the global diabetes drug market reached USD 79.25 billion in 2023 and is projected to grow at a 7.0% CAGR through 2032.
